Guangdong FDA Fails 81 Drugs, Blacklists 4 Listed Pharma In 2Q Drug Evaluations
This article was originally published in PharmAsia News
Executive Summary
Guangdong FDA announced the results of its second quarter drug evaluations in which 81 drugs in 197 batches failed quality tests.